Heart rate variability is associated with haptoglobin phenotype in patients with coronary artery disease

Jeppe Hagstrup Christensen1, Henrik Bygum Krarup, Sam Riahi

  • 1Department of Nephrology, Aalborg Hospital, Aalborg, Denmark. jhc@dadlnet.dk

Insights

The haptoglobin 2-2 phenotype is linked to reduced heart rate variability in coronary artery disease patients. This finding may explain the poorer prognosis observed in individuals with the Hp 2-2 genotype.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Biomarkers

Background:

  • Haptoglobin (Hp) phenotypes (Hp 1-1, Hp 2-2, Hp 2-1) influence coronary artery disease (CAD) risk.
  • The haptoglobin 1 allele may offer partial protection against CAD.
  • Attenuated heart rate variability (HRV) is a predictor of poor outcomes in CAD patients.

Purpose of the Study:

  • To investigate the association between haptoglobin phenotype and heart rate variability in patients with suspected coronary artery disease.

Main Methods:

  • A cross-sectional study involving 255 patients undergoing elective coronary angiography.
  • 24-hour electrocardiogram recordings were used to assess time-domain heart rate variability.
  • Haptoglobin phenotype was determined for all participants.

Main Results:

  • Patients with the Hp 2-2 phenotype (n=98) exhibited significantly lower 24-h HRV compared to those with Hp 1-1 or Hp 2-1 (n=159).
  • Specific HRV parameters (RR, RMSSD, pNN50) were significantly reduced in the Hp 2-2 group.
  • Hp 2-2 was independently associated with attenuated HRV (P=0.02).

Conclusions:

  • The Hp 2-2 phenotype is associated with reduced heart rate variability in patients with coronary artery disease.
  • This association may contribute to the understanding of the poorer prognosis reported in Hp 2-2 patients.
  • Haptoglobin phenotype could serve as a prognostic biomarker in cardiovascular disease.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...